Cargando…

Understanding mortality in multiple myeloma: Findings of a European retrospective chart review

OBJECTIVES: This study aimed to provide real‐world data on the characteristics and treatment of patients with multiple myeloma (MM) at the time of death. METHODS: The study was a retrospective patient chart review across France, Germany, Italy, Spain and the UK during 2016, and included patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohty, Mohamad, Cavo, Michele, Fink, Leah, Gonzalez‐McQuire, Sebastian, Leleu, Henri, Mateos, Maria‐Victoria, Raab, Marc S., Schoen, Paul, Yong, Kwee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851592/ https://www.ncbi.nlm.nih.gov/pubmed/31112311 http://dx.doi.org/10.1111/ejh.13264

Ejemplares similares

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review
por: Hájek, Roman, et al.
Publicado: (2020)

P15: EVOLUTION OF MULTIPLE MYELOMA TREATMENT PATTERNS FROM 2015 THROUGH 2019: REAL-WORLD EVIDENCE FROM A EUROPEAN DATABASE STUDY
por: Oriol Rocafiguera, A, et al.
Publicado: (2022)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
por: Hájek, Roman, et al.
Publicado: (2019)

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE
por: Mateos, M, et al.
Publicado: (2022)

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2020)

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2021)

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2018)

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
por: Bouwmeester, Walter, et al.
Publicado: (2019)

Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data
por: Campioni, M., et al.
Publicado: (2019)

Selective Metaphor Impairments After Left, Not Right, Hemisphere Injury
por: Cardillo, Eileen R., et al.
Publicado: (2018)

P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES
por: Mateos, Maria-Victoria, et al.
Publicado: (2023)

Erratum to: Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis
por: McQuire, Cheryl, et al.
Publicado: (2016)

Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis
por: McQuire, Cheryl, et al.
Publicado: (2015)

P886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL
por: Mateos, Maria-Victoria, et al.
Publicado: (2023)

Forecasting the 2021 local burden of population alcohol‐related harms using Bayesian structural time–series
por: McQuire, Cheryl, et al.
Publicado: (2019)

The causal web of foetal alcohol spectrum disorders: a review and causal diagram
por: McQuire, Cheryl, et al.
Publicado: (2019)

Global disparities in patients with multiple myeloma: a rapid evidence assessment
por: Mateos, Maria-Victoria, et al.
Publicado: (2023)

Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making
por: Gonzalez-McQuire, Sebastian, et al.
Publicado: (2019)

Immunotherapy for Multiple Myeloma
por: Kröger, Nicolaus, et al.
Publicado: (2012)

Flying under the radar: figurative language impairments in focal lesion patients
por: Ianni, Geena R., et al.
Publicado: (2014)

Management of patients with multiple myeloma during the COVID-19 pandemic
por: Malard, Florent, et al.
Publicado: (2020)

P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3
por: Leleu, Xavier, et al.
Publicado: (2023)

T203. RELEVANT CLOZAPINE BLOOD LEVELS USING A POINT OF CARE TEST (POCT)
por: Kelly, Deanna, et al.
Publicado: (2020)

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
por: Musto, Pellegrino, et al.
Publicado: (2021)

CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
por: Cavo, Michele
Publicado: (2023)

Front-line treatment of multiple myeloma
por: Cavo, Michele, et al.
Publicado: (2019)

Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS)
por: Verelst, Silvia G.R., et al.
Publicado: (2018)

Identifying Educational Needs and Practice Gaps of European Hematologists and Hematology Nurses in the Treatment and Management of Multiple Myeloma
por: Murray, Suzanne, et al.
Publicado: (2018)

Bat3 deficiency accelerates the degradation of Hsp70-2/HspA2 during spermatogenesis
por: Sasaki, Toru, et al.
Publicado: (2008)

The Neural Basis of Metaphor Comprehension: Evidence from Left Hemisphere Degeneration
por: Klooster, Nathaniel, et al.
Publicado: (2020)

Conceptualising natural and quasi experiments in public health
por: de Vocht, Frank, et al.
Publicado: (2021)

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives
por: Gay, Francesca, et al.
Publicado: (2018)

Charting the European Course to the High-Energy Frontier
por: Aslanides, E., et al.
Publicado: (2019)

Use of National and International Growth Charts for Studying Height in European Children: Development of Up-To-Date European Height-For-Age Charts
por: Bonthuis, Marjolein, et al.
Publicado: (2012)

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
por: Richardson, Paul G., et al.
Publicado: (2021)

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when
por: Caers, Jo, et al.
Publicado: (2018)

Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
por: Mohty, Mohamad, et al.
Publicado: (2020)

The Burden of a Multiple Myeloma Diagnosis on Patients and Caregivers in the First Year: Western European Findings
por: Gatopoulou, Xenia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uth4qqmqo4sl35ri1746uq8oo7